Publications by authors named "Dong-yu Wang"

The polarization splitter-rotator (PSR) is a key device for polarization processing in polarization diversity systems, which has wide applications in achieving polarization independence and mixed multiplexing. However, it remains a significant challenge to simultaneously achieve a better balance in bandwidth, crosstalk (CT), polarization extinction ratio (PER), and compact footprint of the PSR. In this article, a photonic crystal nanobeam (PCN) structure is introduced to PSR for large bandwidth and compact size, with a device length of only 104 µm.

View Article and Find Full Text PDF

In this editorial, we review the article "Efficacy and predictive factors of transarterial chemoembolization combined with lenvatinib plus programmed cell death protein-1 inhibition for unresectable hepatocellular carcinoma". We specifically focused on whether transarterial chemoembolization combined with lenvatinib in combination with a programmed death 1 inhibitor could be used in patients with unresectable hepatocellular carcinoma. Since both transarterial chemoembolization as well as lenvatinib in combination with programmed death 1 inhibitors play an important role in the treatment of advanced liver cancer, but the combination of all three therapeutic approaches needs more research.

View Article and Find Full Text PDF
Article Synopsis
  • Osteoporosis is a widespread disease causing significant economic strain, driven by imbalances in bone loss and formation due to malfunctioning osteoclasts and osteoblasts.
  • Research has highlighted the impact of immune response and inflammation on osteoporosis development, with specific cytokines influencing the behavior of macrophage subtypes.
  • Bilobalide (Bil), an active compound from Ginkgo biloba, shows promise in reducing osteoclast generation and enhancing bone density, making it a potential treatment for osteoporosis management.
View Article and Find Full Text PDF
Article Synopsis
  • The spread of tumor cells to essential organs significantly contributes to cancer-related deaths.
  • This process, known as metastasis, complicates the treatment and management of various cancers.
  • Understanding the mechanisms behind this spread is crucial for developing better therapies to improve patient outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the differences in cancer drivers between primary and metastatic breast cancer using genetic techniques in female mice, focusing on mutations involving the Rb gene, which is often inactive in this type of cancer.
  • - Researchers identified specific gene insertion sites (gCIS) that are linked to either primary tumors, metastases, or both, highlighting significant networks related to cancer progression, including a shared MET-RAS network and additional pathways for metastatic cancer.
  • - Analysis of human clinical data reveals that certain genetic factors are more prevalent in primary tumors or metastases, suggesting targeted treatments that inhibit specific signaling pathways (like RB1, MET, and RHO) could help block tumor cell migration and improve outcomes for metastatic breast cancer patients.
View Article and Find Full Text PDF

Immune-checkpoint (IC) modulators like the poliovirus receptor (PVR) and programmed death ligand 1 (PD-L1) attenuate innate and adaptive immune responses and are potential therapeutic targets for diverse malignancies, including triple-negative breast cancer (TNBC). The retinoblastoma tumor suppressor, pRB, controls cell growth through E2F1-3 transcription factors, and its inactivation drives metastatic cancer, yet its effect on IC modulators is contentious. Here, we show that RB-loss and high E2F1/E2F2 signatures correlate with expression of PVR, CD274 (PD-L1 gene) and other IC modulators and that pRB represses whereas RB depletion and E2F1 induce PVR and CD274 in TNBC cells.

View Article and Find Full Text PDF

A novel mixture of glycopeptides was prepared from corn glutelin and glucosamine (GlcN). The functional properties and antioxidative activities of this mixture were investigated. Corn glutelin was limited hydrolyzed by Alcalase, and then its hydrolysates were glycosylated with GlcN by transglutaminase (TGase) to modify its main and side chain, respectively.

View Article and Find Full Text PDF

A robust Stille -difluoroallylation of arylstannanes with 3-bromo-3,3-difluoropropenes has been established. The catalyst was found to exert critical effect on the reaction chemoselectivity. By using Pd(OH)/C as the catalyst, a series of 3-(hetero)aryl/vinyl-3,3-difluoropropenes were obtained in high efficiency with α-substitution regioselectivity.

View Article and Find Full Text PDF

Sulfamates and sulfamides are prevalent in biological molecules, but their universal synthetic methods are limited. We herein report a sulfamoylation agent with high solubility and shelf stability. Various sulfamates and sulfamides can be synthesized directly from alcohols or amines by employing this agent with high selectivity and high yields.

View Article and Find Full Text PDF

Pineoblastoma is a rare pediatric cancer induced by germline mutations in the tumor suppressors RB1 or DICER1. Presence of leptomeningeal metastases is indicative of poor prognosis. Here we report that inactivation of Rb plus p53 via a WAP-Cre transgene, commonly used to target the mammary gland during pregnancy, induces metastatic pineoblastoma resembling the human disease with 100% penetrance.

View Article and Find Full Text PDF

A visible light-promoted difluoroalkylation reaction of arenes or heterocycles, using triaryl phosphine as the catalyst and difluoroalkyl iodide as the alkylating agent, is presented. The strategy is highlighted by photocatalyst-free, mild reaction conditions and a broad substrate scope. Mechanistic experiments indicate that this reaction involves a radical-chain process that is initiated by an electron donor-acceptor complex formed from difluoroalkyl iodide and phosphine.

View Article and Find Full Text PDF

Triple-negative breast cancer (TNBC) has been subdivided into six distinct subgroups: basal-like 1 (BL1), basal-like 2 (BL2), mesenchymal (M), mesenchymal stem-like (MSL), immunomodulatory (IM), and luminal androgen receptor (LAR). We recently identified a subgroup of TNBC with loss of the tumor suppressor PTEN and five specific microRNAs that exhibits exceedingly poor clinical outcome and contains TP53 mutation, RB1 loss and high MYC and WNT signalling. Here, show that these PTEN-low/miRNA-low lesions cluster with BL1 TNBC.

View Article and Find Full Text PDF

Aryl-heteroatom bonds (C-Het) are almost ubiquitously present in chemical molecules. However, methods for diverse C-Het bond formations from a simple substrate are limited. Herein, we report a convenient and efficient C-S bond transformation of aryl sulfoniums to various C-Het bonds (C-O, C-S, C-Sn, C-Si, C-Se) in the absence of any transition-metal catalyst.

View Article and Find Full Text PDF

Aryl-heteroatom (C-X) bonds ubiquitously exist in organic, medicinal, and material chemistry, but a universal method to construct diverse C-X bonds is lacking. Here we report our discovery of a convenient and efficient approach to construct various C-X bonds using arylammonium salts as the substrate via an SAr process. This strategy features mild reaction condition, no request of transition metal catalyst, and easy formation of various C-X bonds (C-S, C-Si, C-Sn, C-Ge, C-Se, C-N).

View Article and Find Full Text PDF

Background: Triple-negative breast cancer (TNBC) represents a heterogeneous group of ER- and HER2-negative tumors with poor clinical outcome. We recently reported that Pten-loss cooperates with low expression of microRNA-145 to induce aggressive TNBC-like lesions in mice. To systematically identify microRNAs that cooperate with PTEN-loss to induce aggressive human BC, we screened for miRNAs whose expression correlated with PTEN mRNA levels and determined the prognostic power of each PTEN-miRNA pair alone and in combination with other miRs.

View Article and Find Full Text PDF
Article Synopsis
  • CDC25 is a dual phosphatase that has been identified as a key target for various triple-negative breast cancers, especially those lacking certain genetic features.
  • Inhibitors that block CDC25 show promising results when combined with PI3K inhibitors, leading to better suppression of tumor growth.
  • The text highlights the potential of CDC25 inhibitors in cancer treatment while also addressing the challenges of making these treatments available in clinical settings.
View Article and Find Full Text PDF
Article Synopsis
  • * In triple-negative breast cancer (TNBC), RB1 is often inactivated alongside PTEN and TP53, leading researchers to conduct inhibitor screens on cell lines that lack these tumor suppressors.
  • * The study identified CDC25 phosphatase as a promising therapeutic target, showing that inhibiting CDC25 can suppress the growth of RB1-deficient TNBC cells, especially when combined with WEE1 and PI3K inhibitors.
View Article and Find Full Text PDF

We have developed a simple and direct method for the synthesis of aryl ethers by reacting alcohols/phenols (ROH) with aryl ammonium salts (ArNMe ), which are readily prepared from anilines (ArNR' , R'=H or Me). This reaction proceeds smoothly and rapidly (within a few hours) at room temperature in the presence of a commercially available base, such as KO Bu or KHMDS, and has a broad substrate scope with respect to both ROH and ArNR' . It is scalable and compatible with a wide range of functional groups.

View Article and Find Full Text PDF

Almost all genomic studies of breast cancer have focused on well-established tumours because it is technically challenging to study the earliest mutational events occurring in human breast epithelial cells. To address this we created a unique dataset of epithelial samples ductoscopically obtained from ducts leading to breast carcinomas and matched samples from ducts on the opposite side of the nipple. Here, we demonstrate that perturbations in mRNA abundance, with increasing proximity to tumour, cannot be explained by copy number aberrations.

View Article and Find Full Text PDF

We report a direct cross-coupling reaction between diarylzinc (Ar Zn) and aryltrimethylammonium salts (ArNMe ⋅ OTf) in the presence of LiCl, via C-N bond cleavage. The reaction takes place smoothly upon heating in THF without any external catalyst, enabling an efficient and chemoselective formation of biaryl products. Mechanistic studies indicate that the reaction proceeds through a single electron transfer route.

View Article and Find Full Text PDF
Article Synopsis
  • The PTEN gene, a tumor suppressor, is often inactivated in breast cancer, which may require additional genetic events for tumor formation despite germ-line mutations leading to nonmalignant growths.
  • Most tumors from PTEN deletion in mice are well-differentiated and do not contain transplantable tumor-initiating cells, except for a rare poorly differentiated type that does.
  • Poorly differentiated tumors show unique genetic features and reduced levels of microRNA-143/145; when this microRNA is knocked down, it increases tumor formation by activating RAS signaling, which is linked to worse outcomes in patients, especially in basal-like breast cancer cases.
View Article and Find Full Text PDF

A removable oxime-assisted meta-C-H nitration of arenes is reported. Mechanistic investigations and DFT calculations reveal a new monomeric octahedral ruthenium(II) complex is responsible for the meta-selective nitration. Dioxygen as a cooxidant is crucial for achieving high conversion and good yields.

View Article and Find Full Text PDF

Various aryl-, alkenyl-, and/or alkyllithium species reacted smoothly with aryl and/or benzyl ethers with cleavage of the inert C-O bond to afford cross-coupled products, catalyzed by commercially available [Ni(cod) ] (cod=1,5-cyclooctadiene) catalysts with N-heterocyclic carbene (NHC) ligands. Furthermore, the coupling reaction between the aryllithium compounds and aryl ammonium salts proceeded under mild conditions with C-N bond cleavage in the presence of a [Pd(PPh ) Cl ] catalyst. These methods enable selective sequential functionalizations of arenes having both C-N and C-O bonds in one pot.

View Article and Find Full Text PDF

Cross-coupling is a fundamental reaction in the synthesis of functional molecules, and has been widely applied, for example, to phenols, anilines, alcohols, amines and their derivatives. Here we report the Ni-catalysed Stille cross-coupling reaction of quaternary ammonium salts via C-N bond cleavage. Aryl/alkyl-trimethylammonium salts [Ar/R-NMe] react smoothly with arylstannanes in 1:1 molar ratio in the presence of a catalytic amount of commercially available Ni(cod) and imidazole ligand together with 3.

View Article and Find Full Text PDF